Heinrich-Heine-University,
Medical Faculty,
Institute of Biochemistry & Molecular Biology I,
Universitaetsstr. 1,
D-40225 Duesseldorf,
Germany
 | peter.brenneisen@hhu.de |
Curriculum vitae (CV)
Prof. Dr. rer. nat. Peter Brenneisen (PhD, MSc)
Upon his Master of Science (M.Sc. in Biology/Biochemistry (major subjects biochemistry, organic chemistry, microbiology, genetics), magna cum laude), Peter Brenneisen got his PhD in Cell Biology & Genetics in 1994 (summa cum laude) and his postdoctoral lecture qualification/habilitation (State Doctorate) in Physiological Chemistry/Biochemistry in 2000. In 2001, he initiated a laboratory of redox signaling at the Institute of Biochemistry & Molecular Biology I (under the direction of then Prof. Dr. Helmut Sies), Medical Faculty of the Heinrich-Heine-University, Düsseldorf, Germany. In 2005, he was nominated a (extraordinary, associate) professorship and permanent position at the Medical Faculty. He is involved (and responsible) in teaching medical students in biochemistry, molecular biology, and cell biology. He is author of more than 120 publications (original papers, book chapters, published abstracts) in these topics.
Over the last 30 years, he has focused his scientific interests on different cell biological, biochemical, and molecular biological topics including e.g. reactive oxygen species-dependent molecular mechanism (redox biology) underlying (photo)aging, tumor-stroma interactions and tumor invasion/metastasis. His current research comprises alternative, supplemental, and novel anticancer strategies with the main focus on the underlying molecular and biochemical mechanisms of redox-active nanoparticles and natural compounds in modulation of tumor growth and tumor-stroma interactions (drug repurposing, "new battles with old weapons"). He was nominated a member of the American Nano Society. He is reviewer for numerous scientific journals and editorial board member of the journal Antioxidants (Basel) and Frontiers in Bioscience (Landmark) (see also www.researchgate.net/profile/Peter-Brenneisen, follow us on X (Twitter) @BrenneisenLab).
(Short term) Fellowships:
1) Stanford-University, Department of Biological Sciences (Prof. Dr. P. C. Hanawalt), March 1993, Palo Alto (USA)
2) Massachusetts General Hospital, Harvard Medical School, Wellman Laboratories of Photomedicine (Prof. Dr. I. E. Kochevar), March - May 1997, Boston (USA)
Honors:
1997: Poster prize: XXIV. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung, Leipzig
1997: Young Investigator Award: 7th Annual Meeting of the European Tissue Repair Society, Köln
1999: Poster prize: XXVI. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung, Bonn
Memberships:
American Nano Society
Editorial Board:
Antioxidants (Basel)
Frontiers in Bioscience - Landmark
Research interests (currently):
Tumor-stroma interactions I: molecular mechanisms underlying transdifferentiation of stromal cells – modulation of invasive capacity of tumor cells by antioxidant/prooxidant approaches
Tumor-stroma interactions II: effect of redox-active nanoparticles in modulation of the tumor-stroma – molecular mechanisms underlying their (bi)functional role with focus on redox signaling
Tumor-stroma interactions III: development of novel/alternative combinational anticancer therapies (drug repurposing) including natural compounds and classical chemotherapeutics
Peter Brenneisen
Düsseldorf, in January 2024
Prof. Dr. rer. nat. Peter Brenneisen (PhD, MSc)
Upon his Master of Science (M.Sc. in Biology/Biochemistry (major subjects biochemistry, organic chemistry, microbiology, genetics), magna cum laude), Peter Brenneisen got his PhD in Cell Biology & Genetics in 1994 (summa cum laude) and his postdoctoral lecture qualification/habilitation (State Doctorate) in Physiological Chemistry/Biochemistry in 2000. In 2001, he initiated a laboratory of redox signaling at the Institute of Biochemistry & Molecular Biology I (under the direction of then Prof. Dr. Helmut Sies), Medical Faculty of the Heinrich-Heine-University, Düsseldorf, Germany. In 2005, he was nominated a (extraordinary, associate) professorship and permanent position at the Medical Faculty. He is involved (and responsible) in teaching medical students in biochemistry, molecular biology, and cell biology. He is author of more than 120 publications (original papers, book chapters, published abstracts) in these topics.
Over the last 30 years, he has focused his scientific interests on different cell biological, biochemical, and molecular biological topics including e.g. reactive oxygen species-dependent molecular mechanism (redox biology) underlying (photo)aging, tumor-stroma interactions and tumor invasion/metastasis. His current research comprises alternative, supplemental, and novel anticancer strategies with the main focus on the underlying molecular and biochemical mechanisms of redox-active nanoparticles and natural compounds in modulation of tumor growth and tumor-stroma interactions (drug repurposing, "new battles with old weapons"). He was nominated a member of the American Nano Society. He is reviewer for numerous scientific journals and editorial board member of the journal Antioxidants (Basel) and Frontiers in Bioscience (Landmark) (see also www.researchgate.net/profile/Peter-Brenneisen, follow us on X (Twitter) @BrenneisenLab).
(Short term) Fellowships:
1) Stanford-University, Department of Biological Sciences (Prof. Dr. P. C. Hanawalt), March 1993, Palo Alto (USA)
2) Massachusetts General Hospital, Harvard Medical School, Wellman Laboratories of Photomedicine (Prof. Dr. I. E. Kochevar), March - May 1997, Boston (USA)
Honors:
1997: Poster prize: XXIV. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung, Leipzig
1997: Young Investigator Award: 7th Annual Meeting of the European Tissue Repair Society, Köln
1999: Poster prize: XXVI. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung, Bonn
Memberships:
American Nano Society
Editorial Board:
Antioxidants (Basel)
Frontiers in Bioscience - Landmark
Research interests (currently):
Tumor-stroma interactions I: molecular mechanisms underlying transdifferentiation of stromal cells – modulation of invasive capacity of tumor cells by antioxidant/prooxidant approaches
Tumor-stroma interactions II: effect of redox-active nanoparticles in modulation of the tumor-stroma – molecular mechanisms underlying their (bi)functional role with focus on redox signaling
Tumor-stroma interactions III: development of novel/alternative combinational anticancer therapies (drug repurposing) including natural compounds and classical chemotherapeutics
Peter Brenneisen
Düsseldorf, in January 2024
